On the very day that headlines vibrated all around the world that the diabetes drug Avandia causes heart attacks - a 60-year-old Texas man died from an Avandia fatal heart attack.Avandia, the brand name for Rosiglitazone, first gained approval from the U.S. Food and Drug Administration in May 1999. In 2006, doctors wrote 13 million prescriptions for Avandia and sales totaled $2.2 billion.
Since the New England Journal of Medicine study was published, Avandia's share of new prescriptions has dropped. At the same time, investors have filed a class-action lawsuit against GlaxoSmithKline, claiming the company failed to adequately disclose information linking use of Avandia to an elevated risk of heart trouble.
Source: http://sev.prnewswire.com/health-care-hospitals/20070620/LAW09420062007-1.html
